Список литературы к главе 7

1. Coustan D.R., Lowe L.P., Metzger B.E., Dyer A.R; International Association of Diabetes and Pregnancy Study Groups. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus // Am. J. Obstet. Gynecol. 2010. Vol. 202, N 6. P. 654.e1–654.e6. DOI: 10.1016/j.ajog.2010.04.006.

2. Айламазян Э.К., Абашова Е.И., Коган И.Ю. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.

3. Brown H.K., Speechley K.N., Macnab J., Natale R., Campbell M.K. Biological determinants of spontaneous late preterm and early term birth: a retrospective cohort study // BJOG. 2015. Vol. 122, N 4. P. 491–499. DOI: 10.1111/1471-0528.13191.

4. Born too soon: the global action report on preterm birth / eds.: C.P. Howson, M.V. Kinney, J.E. Lawn. World Health Organization, 2012. 112 р.

5. Persson M., Norman M., Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study // Diabetes Care. 2009. Vol. 32, N 11. P. 2005–2009. DOI: 10.2337/dc09-0656.

6. Murphy H.R., Bell R., Cartwright C., Curnow P., Maresh M., Morgan M. et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study // Diabetologia. 2017. Vol. 60, N 9. P. 1668–1677. DOI: 10.1007/s00125-017-4314-3.

7. Billionnet C., Mitanchez D., Weill A., Nizard J., Alla F., Hartemann A., Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 // Diabetologia. 2017. Vol. 60, N 4. P. 636–644. DOI: 10.1007/s00125-017-4206-6.

8. Eidem I., Vangen S., Hanssen K.F., Vollset S.E., Henriksen T., Joner G., Stene L.C. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes // Diabetologia. 2011. Vol. 54, N 11. P. 2771–2778. DOI: 10.1007/s00125-011-2281-7.

9. Hedderson M.M., Ferrara A., Sacks D.A. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth // Obstet. Gynecol. 2003. Vol. 102, N 4. P. 850–856. DOI: 10.1016/s0029-7844(03)00661-6.

10. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 201: pregestational diabetes mellitus // Obstet. Gynecol. 2018. Vol. 132, N 6. P. e228–e248. DOI: 10.1097/AOG.0000000000002960.

11. National Collaborating Centre for Women’s and Children’s Health (UK). Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. London: National Institute for Health and Care Excellence (UK), 2015. PMID: 25950069.

12. Melamed N., Chen R., Soiberman U., Ben-Haroush A., Hod M., Yogev Y. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors // Arch. Gynecol. Obstet. 2008. Vol. 278, N 2. P. 129–134. DOI: 10.1007/s00404-007-0541-z.

13. Ludvigsson J.F., Neovius M., Söderling J., Gudbjörnsdottir S., Svensson A.M., Franzén S. et al. Maternal Glycemic control in type 1 diabetes and the risk for preterm birth: a population-based cohort study // Ann. Intern. Med. 2019. Vol. 170, N 10. P. 691–701. DOI: 10.7326/M18-1974.

14. Köck K., Köck F., Klein K., Bancher-Todesca D., Helmer H. Diabetes mellitus and the risk of preterm birth with regard to the risk of spontaneous preterm birth // J. Matern. Fetal. Neonatal. Med. 2010. Vol. 23, N 9. P. 1004–1008. DOI: 10.3109/14767050903551392.

15. Lauszus F.F., Fuglsang J., Flyvbjerg A., Klebe J.G. Preterm delivery in normoalbuminuric, diabetic women without preeclampsia: the role of metabolic control // Eur. J. Obstet. Gynecol. Reprod. Biol. 2006. Vol. 124, N 2. P. 144–149. DOI: 10.1016/j.ejogrb.2005.05.015.

16. Farrar D., Fairley L., Santorelli G., Tuffnell D., Sheldon T.A., Wright J. et al. Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort // Lancet Diabetes Endocrinol. 2015. Vol. 3, N 10. P. 795–804. DOI: 10.1016/S2213-8587(15)00255-7.

17. Kovilam O., Khoury J., Miodovnik M., Chames M., Spinnoto J., Sibai B. Spontaneous preterm delivery in the type 1 diabetic pregnancy: the role of glycemic control // J. Matern. Fetal. Neonatal. Med. 2002. Vol. 11, N 4. P. 245–248. DOI: 10.1080/jmf.11.4.245.248.

18. Евсюкова И.И., Кошелева Н.Г. Сахарный диабет: беременные и новорожденные. Санкт-Петербург: Спец. лит., 1996. 268 с.

19. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins– Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy // Obstet. Gynecol. 2019. Vol. 133, N 1. P. e26–e50. DOI: 10.1097/AOG.0000000000003020.

20. Rosenberg T.J., Garbers S., Lipkind H., Chiasson M.A. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups // Am. J. Public Health. 2005. Vol. 95, N 9. P. 1545–1551. DOI: 10.2105/AJPH.2005.065680.

21. Cnattingius S., Villamor E., Johansson S., Edstedt Bonamy A.K., Persson M., Wikström A.K., Granath F. Maternal obesity and risk of preterm delivery // JAMA. 2013. Vol. 309, N 22. P. 2362–2370. DOI: 10.1001/jama.2013.6295.

22. Аржанова О.Н., Кошелева Н.Г. Особенности течения беременности и родов при сахарном диабете в современных условиях // Журнал акушерства и женских болезней. 2006. Т. LV, № 1. С. 12–16.

23. Galindo A., Burguillo A.G., Azriel S., Fuente Pde L. Outcome of fetuses in women with pregestational diabetes mellitus // J. Perinat. Med. 2006. Vol. 34, N 4. P. 323–331. DOI: 10.1515/JPM.2006.062.

24. Преждевременные роды: клинические рекомендации РОАГ, АААР. Москва, 2020. 66 с.

25. Becquet O., El Khabbaz F., Alberti C., Mohamed D., Blachier A., Biran V. et al. Insulin treatment of maternal diabetes mellitus and respiratory outcome in late-preterm and term singletons // BMJ Open. 2015. Vol. 5, N 6. P. e008192. DOI: 10.1136/bmjopen-2015-008192.

26. Piper J.M. Lung maturation in diabetes in pregnancy: if and when to test // Semin. Perinatol. 2002. Vol. 26, N 3. P. 206–209. DOI: 10.1053/sper.2002.33969.

27. Groom K.M. Antenatal corticosteroids after 34 weeks’ gestation: do we have the evidence? // Semin. Fetal. Neonatal. Med. 2019. Vol. 24, N 3. P. 189–196. DOI: 10.1016/j.siny.2019.03.001.

28. Fung G.P., Chan L.M., Ho Y.C., To W.K., Chan H.B., Lao T.T. Does gestational diabetes mellitus affect respiratory outcome in late-preterm infants? // Early Hum. Dev. 2014. Vol. 90, N 9. P. 527–530. DOI: 10.1016/j.earlhumdev.2014.04.006.

29. Gewolb I.H. Effect of high glucose on fetal lung maturation at different times in gestation // Exp. Lung. Res. 1996. Vol. 22, N 2. P. 201–211. DOI: 10.3109/01902149609050847.

30. Sosenko I.R., Frantz I.D. 3rd, Roberts R.J., Meyrick B. Morphologic disturbance of lung maturation in fetuses of alloxan diabetic rabbits // Am. Rev. Respir. Dis. 1980. Vol. 122, N 5. P. 687–695. DOI: 10.1164/arrd.1980.122.5.687.

31. Baack M.L., Forred B.J., Larsen T.D., Jensen D.N., Wachal A.L., Khan M.A., Vitiello P.F. Consequences of a maternal high-fat diet and late gestation diabetes on the developing rat lung // PLoS One. 2016. Vol. 11, N 8. P. e0160818. DOI: 10.1371/journal.pone.0160818.

32. Piper J.M., Xenakis E.M., Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies // J. Matern. Fetal. Med. 1998. Vol. 7, N 3. P. 148–153. DOI: 10.1002/(SICI)1520-6661(199805/06)7:3<148::AID-MFM9>3.0.CO;2-K.

33. Elmekkawi S.F., Mansour G.M., Elsafty M.S., Hassanin A.S., Laban M., Elsayed H.M. Prediction of fetal hypertrophic cardiomyopathy in diabetic pregnancies compared with postnatal outcome // Clin. Med. Insights Womens Health. 2015. Vol. 8. P. 39–43. DOI: 10.4137/CMWH.S32825.

34. Amiya R.M., Mlunde L.B., Ota E., Swa T., Oladapo O.T., Mori R. Antenatal corticosteroids for reducing adverse maternal and child outcomes in special populations of women at risk of imminent preterm birth: a systematic review and meta-analysis // PLoS One. 2016. Vol. 11, N 2. P. e0147604. DOI: 10.1371/journal.pone.0147604.

35. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth // Cochrane Database Syst. Rev. 2017. Vol. 3, N 3. P. CD004454. DOI: 10.1002/14651858.CD004454.pub3. Update in: Cochrane Database Syst Rev. 2020. Dec 25. N 12. P. CD004454. PMID: 28321847; PMCID: PMC6464568.

36. Padbury J.F., Ervin M.G., Polk D.H. Extrapulmonary effects of antenatally administered steroids // J. Pediatr. 1996. Vol. 128, N 2. P. 167–172. DOI: 10.1016/s0022-3476(96)70384-0.

37. Sifianou P., Thanou V., Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation // J. Pediatr. Pharmacol. Ther. 2015. Vol. 20, N 2. P. 138–143. DOI: 10.5863/1551-6776-20.2.138.

38. Tuohy J.F., Bloomfield F.H., Crowther C.A., Harding J.E. Maternal and neonatal glycaemic control after antenatal corticosteroid administration in women with diabetes in pregnancy: a retrospective cohort study // PLoS One. 2021. Vol. 16, N 2. P. e0246175. DOI: 10.1371/journal.pone.0246175.

39. Sharma A., Davis A., Shekhawat P.S. Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes // Transl. Pediatr. 2017. Vol. 6, N 4. P. 335–348. DOI: 10.21037/tp.2017.10.06.

40. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. Practice Bulletin No. 171: management of preterm labor // Obstet. Gynecol. 2016. Vol. 128, N 4. P. e155–e164. DOI: 10.1097/AOG.0000000000001711.

41. Preterm labour and birth. NICE. 2015. 29 р. [Electronic resource]. URL: https://www.nice.org.uk/guidance/ng25/resources/preterm-labour-and-birth-pdf-1837333576645/ (date of access: August 2, 2019).

42. RCOG. Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation // Green-top Guideline. 2019. Vol. 73. Р. 152–166.

43. Skoll A., Boutin A., Bujold E., Burrows J., Crane J., Geary M. et al. No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes // J. Obstet. Gynaecol. Can. 2018. Vol. 40, N 9. P. 1219–1239. DOI: 10.1016/j.jogc.2018.04.018.

44. Berger H., Gagnon R., Sermer M. Guideline No. 393-diabetes in pregnancy // J. Obstet. Gynaecol. Can. 2019. Vol. 41, N 12. P. 1814–1825. P. e1. DOI: 10.1016/j.jogc.2019.03.008. Erratum in: J. Obstet. Gynaecol. Can. 2020. Vol. 42, N 10. P. 1288. PMID: 31785800.

45. Schäfer-Graf U.M., Gembruch U., Kainer F., Groten T., Hummel S., Hösli I. et al. Gestational diabetes mellitus (GDM) — diagnosis, treatment and follow-up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018) // Geburtshilfe Frauenheilkd. 2018. Vol. 78, N 12. P. 1219–1231. DOI: 10.1055/a-0659-2596.

46. Berger R., Abele H., Bahlmann F., Bedei I., Doubek K., Felderhoff-Müser U. et al. Prevention and therapy of preterm birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) — part 2 with recommendations on the tertiary prevention of preterm birth and the management of preterm premature rupture of membranes // Geburtshilfe Frauenheilkd. 2019. Vol. 79, N 8. P. 813–833. DOI: 10.1055/a-0903-2735.

47. Gyamfi-Bannerman C., Thom E.A., Blackwell S.C., Tita A.T., Reddy U.M., Saade G.R. et al. Antenatal betamethasone for women at risk for late preterm delivery // N. Engl. J. Med. 2016. Vol. 374, N 14. P. 1311–13120. DOI: 10.1056/NEJMoa1516783.

48. Dodd J.M., Jones L., Flenady V., Cincotta R., Crowther C.A. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth // Cochrane Database Syst. Rev. 2013. Vol. 7. P. CD004947. DOI: 10.1002/14651858.CD004947.pub3.